<code id='23087FBE7E'></code><style id='23087FBE7E'></style>
    • <acronym id='23087FBE7E'></acronym>
      <center id='23087FBE7E'><center id='23087FBE7E'><tfoot id='23087FBE7E'></tfoot></center><abbr id='23087FBE7E'><dir id='23087FBE7E'><tfoot id='23087FBE7E'></tfoot><noframes id='23087FBE7E'>

    • <optgroup id='23087FBE7E'><strike id='23087FBE7E'><sup id='23087FBE7E'></sup></strike><code id='23087FBE7E'></code></optgroup>
        1. <b id='23087FBE7E'><label id='23087FBE7E'><select id='23087FBE7E'><dt id='23087FBE7E'><span id='23087FBE7E'></span></dt></select></label></b><u id='23087FBE7E'></u>
          <i id='23087FBE7E'><strike id='23087FBE7E'><tt id='23087FBE7E'><pre id='23087FBE7E'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:6124
          Brain cancer
          Michelle Monje/Stanford University/NIH

          Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

          The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

          advertisement

          “We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          What to expect as Trump is arraigned on his Jan 6. indictment
          What to expect as Trump is arraigned on his Jan 6. indictment

          1:16AHomelandSecuritycanineunitsweepsoneoftheentrancestotheE.BarrettPrettymanU.S.CourthouseinWashing

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Hearing on Medicare drug price negotiation gets unusually heated

          AtaWednesdayhearing,OversightsubcommitteeChairMorganGriffith(R-Va.)mockedMedicaredrugpricenegotiatio